Xenetic Biosciences Valuation
| XBIOWDelisted Stock | USD 17.54 0.00 0.00% |
At this time, the company appears to be overvalued. Xenetic Biosciences maintains a prevalent Real Value of $12.57 per share. The last-minute price of the company is $17.54. Our model calculates the value of Xenetic Biosciences from examining the company fundamentals such as Profit Margin of (1.83) %, revenue of 2.54 M, and Return On Asset of -0.26 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Xenetic Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Xenetic Biosciences is based on 3 months time horizon. Increasing Xenetic Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Xenetic stock is determined by what a typical buyer is willing to pay for full or partial control of Xenetic Biosciences. Since Xenetic Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xenetic Stock. However, Xenetic Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.54 | Real 12.57 | Hype 17.54 | Naive 19.96 |
The intrinsic value of Xenetic Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Xenetic Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Xenetic Biosciences helps investors to forecast how Xenetic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xenetic Biosciences more accurately as focusing exclusively on Xenetic Biosciences' fundamentals will not take into account other important factors: Xenetic Biosciences Total Value Analysis
Xenetic Biosciences is at this time estimated to have takeover price of 0 with market capitalization of 0, debt of 809.59 K, and cash on hands of 2.02 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Xenetic Biosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 809.59 K | 2.02 M |
Xenetic Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xenetic Biosciences has an asset utilization ratio of 23.95 percent. This indicates that the Company is making $0.24 for each dollar of assets. An increasing asset utilization means that Xenetic Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Xenetic Biosciences Profitability Analysis
The company reported the revenue of 2.54 M. Net Loss for the year was (4.13 M) with profit before overhead, payroll, taxes, and interest of 0.About Xenetic Biosciences Valuation
Our relative valuation model uses a comparative analysis of Xenetic Biosciences. We calculate exposure to Xenetic Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Xenetic Biosciences's related companies.Xenetic Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Xenetic Biosciences is traded on BATS Exchange in USA.
Xenetic Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Xenetic Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.5 M |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Xenetic Stock
If you are still planning to invest in Xenetic Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xenetic Biosciences' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |